[1]
2023. Subtype performance of the ancillary diagnostic 23- and 35-gene expression profile (GEP) tests for difficult-to-diagnose melanocytic lesions. SKIN The Journal of Cutaneous Medicine. 7, 3 (May 2023), s214. DOI:https://doi.org/10.25251/skin.7.supp.214.